Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Hepatobiliary Surgery and Nutrition|May 1, 2023
Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter studyWen-Tao Yan, Chao Li, Lan-Qing Yao, et al.
Oncology Letters|December 2, 2015
High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinomaYan Zheng, Yuan-Fang Li, Wei Wang, et al.
Zhonghua Yi Xue Za Zhi|July 12, 2012
[Effect of Xuebijing injection treatment on acute respiratory distress syndrome: a multicenter prospective randomized control clinical trial]Song-qiao LIU, Rui-qiang ZHENG, Mao-qin LI, et al.
Signal Transduction and Targeted Therapy|November 3, 2025
Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational researchHai-Bo Qiu, Zhiyan Liang, Jing Yang, et al.
Plos One|April 5, 2014
Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patientsYan Zheng, Dan-dan Wang, Wei Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 20, 2025
tRF-5004b Enriched Secretory Autophagosomes Induce Endothelial Cell Activation to Drive Acute Respiratory Distress SyndromeXing-Xing Zhu, Han Li, Shuang-Feng Zi, et al.
Annals of Translational Medicine|November 4, 2020
Clinical features and mortality-related factors of extensive burns among young adults: the Kunshan disaster experienceYing-Zi Huang, Guo-Zhong Lu, Hong-Sheng Zhao, et al.
Cancer Communications (London, England)|October 14, 2023
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancerShu-Qiang Yuan, Run-Cong Nie, You-Sheng Huang, et al.
Cell Reports. Medicine|June 18, 2025
Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancerRun-Cong Nie, Xiao-Jiang Chen, Cheng-Cai Liang, et al.
Signal Transduction and Targeted Therapy|February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trialRun-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Pageof 15